Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cipla-Serum add new rung to relationship

This article was originally published in Scrip

Executive Summary

This could be read as growing pre-nuptial synergy between Cipla and the Serum Institute of India. Or maybe the duo's next step in their "relationship" is purely an extension of a previous alliance and one which will see Cipla step up its indirect interest in vaccines play to the Indian market.

Advertisement

Related Content

Cipla Sees Changed Profile; Wraps Up Europe Revamp

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC028831

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel